This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Arch Oncology, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Daniel S Pereira
Introduction
Daniel S Pereira is a notable inventor based in San Diego, CA. He has made significant strides in the field of therapeutic antibodies, particularly focusing on anti-SIRPα monoclonal antibodies. His work aims to provide new avenues for the prevention and treatment of various cancers.
Latest Patents
Daniel holds a patent for "Therapeutic SIRP-α antibodies." This patent includes anti-SIRPα monoclonal antibodies, which are designed with distinct functional profiles. These antibodies, including multispecific SIRPα antibodies, are related to compositions and methods for their use as therapeutics in combating solid and hematological cancers. The patent also provides amino acid sequences of exemplary anti-SIRPα monoclonal antibodies.
Career Highlights
Daniel is currently associated with Arch Oncology, Inc., where he continues to advance his research and development efforts. His innovative approach to cancer treatment through antibody therapy has positioned him as a key figure in the biotechnology sector.
Collaborations
Daniel collaborates with talented professionals in his field, including Robyn Puro and Ronald R Hiebsch. Their combined expertise contributes to the ongoing success of their projects and initiatives.
Conclusion
Daniel S Pereira's contributions to the field of therapeutic antibodies represent a significant advancement in cancer treatment. His innovative work continues to inspire and pave the way for future research in this critical area of medicine.